Observational Study Evaluating the viQtor for Early Detection of Clinical Deterioration in Post-ICU Patients on General Wards

Launched by ERASMUS MEDICAL CENTER · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new device called the viQtor, which continuously monitors vital signs like pulse rate, breathing rate, and oxygen levels in patients who have just been discharged from the ICU and are now in a regular hospital ward. The goal is to see if this device can help doctors detect any health changes more quickly, which could prevent unnecessary hospital readmissions. Researchers will also compare the viQtor's results with a standard early warning score used in hospitals, and they want to know how satisfied both patients and nurses are with this new monitoring approach.

To participate in this study, you need to be at least 18 years old and able to give written consent. You should expect to stay in the hospital for at least two days after leaving the ICU. However, if you cannot communicate in Dutch or English, have allergies to certain materials, or have specific skin issues on your upper arms, you may not be eligible. If you take part, you'll help researchers understand how effective this new monitoring system is and improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults ≥18 years of age
• • Written informed consent is obtained from the patient
• • Expected hospitalization time after ICU discharge of 2 days or longer
• Exclusion Criteria:
• • The patient is unable to communicate in Dutch or English
• • The patient has an allergy to metal or plastics (as the viQtor device contains these materials)
• • The patient has significant deformities, swelling, irritation, degenerative changes, local infection, ulceration, skin lesions, or edema of the upper arms.
• • The patient has tattoos on both upper arms where the device's PPG sensor would be placed
• • The patient experiences tremors/and or convulsions affecting the upper arm